Chargement en cours...
Next Generation Chimeric Antigen Receptor T Cell Therapy: Going off the Shelf
Autologous, patient-specific chimeric antigen receptor T cell (CART) therapy has emerged as a powerful and potentially curative therapy for cancer, especially for CD19-positive hematological malignancies. Indeed, CD19-directed CART (CART-19) cell therapy (tisagenlecleucel-t) was Food and Drug Admini...
Enregistré dans:
| Publié dans: | BioDrugs |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5699508/ https://ncbi.nlm.nih.gov/pubmed/29143249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-017-0247-0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|